Suzhou Connect Biopharmaceuticals
Latest round
- Series C
Last raised
- Aug 2020
Total raised
- $190M
Investors
- 9
About Suzhou Connect Biopharmaceuticals
Founded in 2012 and based in Taicang, China, Suzhou Connect Biopharmaceuticals, Ltd. operates as a biopharmaceutical company that develops therapies for patients with chronic inflammatory diseases.
Who invested in Suzhou Connect Biopharmaceuticals
9 investors across 3 rounds
See all investors in Suzhou Connect Biopharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Suzhou Connect Biopharmaceuticals
Who invested in Suzhou Connect Biopharmaceuticals?
Suzhou Connect Biopharmaceuticals has 9 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Suzhou Connect Biopharmaceuticals raised?
Suzhou Connect Biopharmaceuticals has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Suzhou Connect Biopharmaceuticals last raise money?
Suzhou Connect Biopharmaceuticals's most recent round on record is a Series C, in Aug 2020.
What does Suzhou Connect Biopharmaceuticals do?
Founded in 2012 and based in Taicang, China, Suzhou Connect Biopharmaceuticals, Ltd.
Where is Suzhou Connect Biopharmaceuticals headquartered?
Suzhou Connect Biopharmaceuticals is headquartered in Suzhou, China.
Which VCs invest in companies like Suzhou Connect Biopharmaceuticals?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Suzhou Connect Biopharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Suzhou Connect Biopharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.